)
Visual
test
Cue Biopharma
Cue Biopharma (CUE) investor relations material
Cue Biopharma Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary27 Mar, 2026
Executive summary
Interim President and CEO appointed following the resignation of the previous CEO and board member, effective March 26, 2026.
Board size reduced to six directors as a result of the resignation, with no replacement nominee named.
A separation and release of claims agreement was executed with the outgoing CEO.
Voting matters and shareholder proposals
One director nominee withdrawn due to resignation; remaining nominees continue to stand for election.
Proxy cards and voting instructions for the withdrawn nominee will not be counted for that individual but remain valid for other matters.
No changes to other proposals or items to be acted upon at the annual meeting.
Board of directors and corporate governance
Board composition changed with the resignation of a director and reduction in board size.
Interim leadership established with the appointment of the Chief Financial and Business Officer as Interim President and CEO.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Cue Biopharma
- Biotech seeks up to $300M in securities amid going concern risk and ongoing capital needs.CUE
Registration Filing17 Mar 2026 - Q4 2025 revenue soared on ImmunoScape deal, with CUE-401 advancing and liquidity improved.CUEQ4 202516 Mar 2026
- Key votes include director elections, auditor ratification, and a reverse stock split to support Nasdaq compliance.CUEProxy Filing16 Mar 2026
- Proxy seeks approval for director elections, auditor, executive pay, and a reverse stock split.CUEProxy Filing6 Mar 2026
- Obesity phase III trials advance, with strong oral efficacy and new maintenance strategies underway.CUECantor Global Healthcare Conference 20253 Feb 2026
- Selective immune modulation platform shows strong clinical efficacy and regulatory momentum.CUEJefferies 2024 Global Healthcare Conference1 Feb 2026
- Restructuring and clinical gains drive focus on autoimmune pipeline amid cash constraints.CUEQ2 20241 Feb 2026
- CUE-101 and CUE-102 deliver strong survival benefits, with autoimmune assets advancing via key partnerships.CUEStifel 2024 Healthcare Conference13 Jan 2026
- Immuno-STAT platform delivers strong cancer survival data and advances autoimmune therapies.CUEPiper Sandler 36th Annual Healthcare Conference11 Jan 2026
Next Cue Biopharma earnings date
Status update7 Apr, 2026
Cue Biopharma
Next Cue Biopharma earnings date
Status update7 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage